Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00370604
Other study ID # 1-PAngle
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2007
Est. completion date December 2009

Study information

Verified date June 2022
Source Sunnybrook Health Sciences Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of 19g versus =>18g traditional Tuohy-type epidural needles on the incidence and severity of postdural puncture headache (PDPH).


Description:

A headache is the most significant complication of dural puncture during epidural placement. This complication leads to longer hospital stays and many repeated visits to hospital for management. Women suffering from severe postdural puncture headache (PDPH) are often bedridden and unable to care for themselves or their babies.The efficacy of epidural blood patch as a "gold standard" therapy is over-estimated by the earlier, poor quality studies. The prevalence of dural puncture during epidural anesthesia using current techniques ranges from 0.03 to 6% in the literature. Of these patients, 70 to 80% will suffer from moderate to severe PDPH. Avoidance of dural puncture is always the goal. However, complete avoidance is unlikely using current techniques of needle placement. This study proposes another method of prevention (i.e., reducing the gauge of the epidural needles if it is shown to be suitable for continuous infusion in adults). Most of the risk factors for developing PDPH cannot be changed (e.g., younger age, female sex, low body mass index, history of migraines). However, epidural needle gauge is a modifiable risk factor. Evidence suggests that the use of smaller gauge epidural needles, like spinal needles, have the potential to reduce the incidence and severity of PDPH.


Recruitment information / eligibility

Status Completed
Enrollment 1081
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - American Society of Anesthesiologists status 1 to 2 - Must have provided written informed consent = or < 6cm cervical dilation - Fetus 37 to 42 weeks gestation - Must be able to read and write English well enough to provide written informed consent Exclusion Criteria: - BMI = or > 40 - Multiple gestation pregnancy - Known contraindications to use of epidural analgesia - Pregnancy-induced hypertension - Investigator concern for maternal or neonatal welfare - Receipt of spinal or epidural anesthesia within 14 days of labour epidural request - Women with chronic headaches (defined as headaches that occur 15 or more days per month for more than 3 months) - Already participated in study - History of narcotic abuse

Study Design


Related Conditions & MeSH terms


Intervention

Device:
19g Tuohy-type epidural needle, 23g catheter
Patients in the experimental group will receive a 23g 90cm adult length epidural catheter placed via a 19g Tuohy epidural needle (SIMS Portex, Hythe, UK). The 19g Tuohy needle is a standard 3½ inch length.
=> 18g Tuohy-type needle
Patients in the control arm will receive a traditional large gauge (16g, 17g or 18g Tuohy or Hustead) epidural needle and a traditional epidural catheter. Two control needles and two control catheters will be designated apriori by each institution for use in the study.

Locations

Country Name City State
Canada IWK Health Centre Halifax Nova Scotia
Canada St. Joseph's Hospital London Ontario
Canada Sunnybrook Health Sciences Centre at Women's College Hospital Toronto Ontario
Canada British Columbia Women's Hospital and Health Centre Vancouver British Columbia

Sponsors (3)

Lead Sponsor Collaborator
Sunnybrook Health Sciences Centre Canadian Anesthesiologists' Society, The Physicians' Services Incorporated Foundation

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Angle PJ, Hussain K, Morgan A, Halpern SH, Van der Vyver M, Yee J, Kiss A. High quality labour analgesia using small gauge epidural needles and catheters. Can J Anaesth. 2006 Mar;53(3):263-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of postdural puncture headache within the first 14 days of epidural placement
Secondary PDPH characteristics (quality, distribution, postural versus non-postural nature, associated symptoms) within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Secondary Severity of pain related to PDPH within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Secondary Degree of dysfunction and disability related to PDPH symptoms within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Secondary Duration of PDPH-related symptoms within first 14 days post-epidural placement, and if necessary, up to 1 year post-epidural placement
Secondary Pain and pain relief (first and second stage labor analgesia following epidural placement and overall pain relief) as rated by the patient, compared between groups within 24 hours of epidural placement
Secondary Incidence of persistent PDPH symptoms between groups at 6 weeks post-epidural placement
Secondary Number and timing of epidural blood patches received, total number of epidural blood patches received until symptom resolution within the first 6 weeks of epidural placement
Secondary Risk of delayed block failure for continuous labour analgesia in patients receiving a 19g Tuohy epidural needle and 23g catheter after first 30 minutes of successful initiation (requiring epidural reinsertion)
Secondary Risk of requiring use of an alternative method of anesthesia for operative delivery in patients receiving successful epidural initiation with a 19g Tuohy epidural needle and a 23g catheter during labour and delivery
Secondary Incidence of significant adverse events in each group up to 1 year post-epidural placement
Secondary Patient ratings of overall pain relief compared between groups during labour and delivery
Secondary Anesthesiologist satisfaction with the 19g Tuohy epidural needle and 23g catheter compared with traditional Tuohy type epidural needles and traditional catheters during labour and delivery
See also
  Status Clinical Trial Phase
Completed NCT04091321 - Association Between Chronic Headache and Back Pain With Childbirth
Recruiting NCT05202574 - Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section Phase 2
Terminated NCT02813655 - Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) Phase 2
Completed NCT02522013 - Aminophylline for Patients With Post-Dural Puncture Headache Phase 3
Completed NCT05301387 - The Effect of Ganglion Sphenopalatine Block (GSP-block) Follow-Up
Recruiting NCT05637645 - Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section N/A
Recruiting NCT05116930 - Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture Phase 2
Terminated NCT03430531 - Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache Phase 2
Completed NCT04401878 - SGB in Management of Patients With PDPH Using TCD N/A
Completed NCT04327726 - Effectiveness of Nebulized Dexmedetomidine for Treatment of Obstetric Post-Dural Puncture Headache N/A
Completed NCT03475784 - Two Fluid Strategies for Prevention of Post-dural Puncture Headache Phase 3
Not yet recruiting NCT06272916 - Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.
Terminated NCT02827058 - The Influence of Needle Diameter on Post Dural Puncture Headache N/A
Not yet recruiting NCT05262933 - Effects of Preoperative Coffee Consumption in Cesarean Sections Under Spinal Anesthesia
Completed NCT04793490 - Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients N/A
Recruiting NCT05888324 - Factors Associated With the Onset of Chronic Headaches in Patients Who Received a Blood Patch in Post Partum
Completed NCT04844229 - Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache N/A
Withdrawn NCT03560349 - RCT of SPG Blocks for Post-dural Headache Phase 2
Recruiting NCT06253754 - Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache
Not yet recruiting NCT03385772 - The Sphenopalatine Ganglion Block for Post-dural Puncture Headache N/A